Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongjiang granules for non-erosive reflux disease (liver-stomach constraint heat pattern)
CTR20232976Phase 2Active
- Sponsor
- Jianmin Pharmaceutical Group
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tongjiang granule in gastroesophageal reflux disease (GERD), sponsored by Jianmin Pharmaceutical Group. Started Sep 2023; status: active.
02
Drugs
tongjiang granule
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on CTR20232976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232976.